Functional desensitization to isoproterenol without reducing cAMP production in canine failing cardiocytes

C E Laurent1, R Cardinal, G Rousseau

  • 1Département de Pharmacologie, Faculté de Médecine, Université de Montréal, Québec H3C 3J7, Canada.

Insights

In heart failure, reduced beta-adrenergic receptor (beta-AR) responses in cardiomyocytes stem from excitation-contraction issues, not cAMP signaling defects. This impacts heart function during stress.

Area of Science:

  • Cardiology
  • Molecular Biology
  • Physiology

Background:

  • Beta-adrenergic receptors (beta-ARs) are crucial for regulating cardiac function.
  • Tachycardia-induced heart failure is associated with altered beta-AR signaling.
  • Understanding these alterations is key to developing therapeutic strategies.

Purpose of the Study:

  • To investigate the functional responses to beta-adrenergic receptor (beta-AR) stimulation in failing cardiomyocytes.
  • To compare beta-AR signaling pathways, including cAMP generation, in healthy and failing hearts.
  • To determine the underlying mechanisms responsible for reduced cardiac contractility in heart failure.

Main Methods:

  • Isolated canine cardiomyocytes from healthy and tachycardia-induced heart failure models were used.
  • Contractile function, L-type Ca(2+) current, and cAMP generation in response to isoproterenol were measured.
  • Beta-AR density and subtype ratios (beta(1)/beta(2)) were analyzed in whole tissue and cardiomyocyte homogenates.

Main Results:

  • Failing cardiomyocytes showed depressed basal shortening and reduced maximal responses to isoproterenol.
  • Isoproterenol-stimulated L-type Ca(2+) current was significantly reduced in failing cells.
  • While cAMP generation was similar in isolated cells, it was reduced in whole tissue homogenates, with an altered beta(1)/beta(2) ratio in failing hearts.
  • Total beta-AR density remained unchanged.

Conclusions:

  • Reduced functional responses to beta-AR stimulation in tachycardia-induced heart failure are primarily due to alterations in the excitation-contraction coupling machinery.
  • Limitations in cAMP generation are not the main cause of impaired beta-AR responsiveness in failing cardiomyocytes.
  • The altered beta(1)/beta(2) ratio in whole tissue suggests a potential role in the observed functional deficits.

Related Concept Videos

Heart Failure Drugs: Inotropic Agents01:26

Heart Failure Drugs: Inotropic Agents

Positive inotropic agents are commonly used as the first line of treatment for heart failure. One such agent is digoxin, derived from the genus Digitalis, which has been known for centuries but effectively utilized since 1785. However, these cardiac glycosides can have potentially toxic effects due to their mechanism of action, which involves inhibiting Na+/K+-ATPase and increasing contractility. Digoxin is absorbed orally and distributed in various tissues, including the CNS. It has a long...
Heart Failure Drugs: Inhibitors of Renin-Angiotensin System01:26

Heart Failure Drugs: Inhibitors of Renin-Angiotensin System

The activation of the sympathetic nervous system and the renin-angiotensin-aldosterone system (RAAS) contributes to cardiac remodeling, and inhibiting the RAAS is a pharmacological target in heart failure management. As a result, neurohumoral modulation is a crucial treatment principle for managing heart failure. This approach involves using medications like ACE inhibitors (ACEIs), angiotensin receptor blockers (ARBs), β-blockers, mineralocorticoid receptor antagonists (MRAs), and neutral...
Heart Failure II: Pathophysiology01:29

Heart Failure II: Pathophysiology

Systolic Heart Failure and Compensatory MechanismsSystolic heart failure (also termed HFrEF, Heart Failure with Reduced Ejection Fraction) is the most prevalent type of heart filure. It results in a decreased volume of blood being pumped from the ventricle. The aortic arch and carotid sinuses have baroreceptors that detect reduced blood pressure, triggering the sympathetic nervous system (SNS) to release epinephrine and norepinephrine. Initially, this response aims to boost heart rate and...